Melanoma cell necrosis facilitates transfer of specific sets of antigens onto MHC class II molecules of dendritic cells

European Journal of Immunology

Volumn 35, Issue 10, 2005, Pages 2826-2839

  Röhn, Till A ^a,e   Schadendorf, Dirk ^b   Sun, Yuansheng ^c   Nguyen, Xuan Duc ^d   Roeder, Daniel ^e   Langen, Hanno ^e   Vogt, Anne B ^a,e   Kropshofer, Harald ^a,e  

^a BASEL INSTITUTE FOR IMMUNOLOGY   (Switzerland)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c PAUL EHRLICH INSTITUT   (Germany)

^d Institute of Transfusion Medicine and Immunology   (Germany)

^e F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Antigen presentation; Heat shock proteins; T helper cells; Tumor antigens; Vaccines

Indexed keywords

DENDRITIC CELL VACCINE; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 73; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; BINDING COMPETITION; CELL ASSAY; CELL DEATH; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; DRUG TARGETING; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; MELANOMA; MELANOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; APOPTOSIS; BLOTTING, WESTERN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; COCULTURE TECHNIQUES; DENDRITIC CELLS; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS II; HSP70 HEAT-SHOCK PROTEINS; HUMANS; LYMPHOCYTE ACTIVATION; MELANOMA; MICE; NECROSIS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 27644535766     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200526299     Document Type: Article

References (53)

1. Schadendorf, D. and Nestle, F. O., Autologous dendritic cells for treatment of advanced cancer - an update. Recent Results Cancer Res. 2001. 158: 236-248.
2. Rosenberg, S. A., Progress in human tumour immunology and immunotherapy. Nature 2001. 411: 380-384.
3. Albert, M. L., Sauter, B. and Bhardwaj, N., Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998. 392: 86-89.
4. Gallucci, S., Lolkema, M. and Matzinger, P., Natural adjuvants: Endogenous activators of dendritic cells. Nat. Med. 1999. 5: 1249-1255.
5. Kotera, Y., Shimizu, K. and Mule, J. J., Comparative analysis of necrotic and apoptotic tumor cells as a source of antigen(s) in dendritic cell-based immunization. Cancer Res. 2001. 61: 8105-8109.
6. Sauter, B., Albert, M. L., Francisco, L., Larsson, M., Somersan, S. and Bhardwaj, N., Consequences of cell death: Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 2000. 191: 423-434.
7. + T cell help. J. Exp. Med. 1997. 186: 65-70.
8. Nouri-Shirazi, M., Banchereau, J., Bell, D., Burkeholder, S., Kraus, E. T., Davoust, J. and Palucka, K. A., Dendritic cells capture killed tumor cells and present their antigens to elicit tumor-specific immune responses. J. Immunol. 2000. 165: 3797-3803.
9. + T cells in antitumor immunity. Trends Immunol. 2001. 22: 269-276.
10. Banchereau, J. and Steinman, R. M., Dendritic cells and the control of immunity. Nature 1998. 392: 245-252.
11. Sallusto, F., Cella, M., Danieli, C. and Lanzavecchia, A., Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: Downregulation by cytokines and bacterial products. J. Exp. Med. 1995. 182: 389-400.
12. Cella, M., Engering, A., Pinet, V., Pieters, J. and Lanzavecchia, A., Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 1997. 388: 782-787.
13. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. J., Pulendran, B. and Palucka, K., Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000. 18: 767-811.
14. Kaisho, T. and Akira, S., Dendritic-cell function in Toll-like receptor- and MyD88-knockout mice. Trends Immunol. 2001. 22: 78-83.
15. Rovere, P., Vallinoto, C., Bondanza, A., Crosti, M. C., Rescigno, M., Ricciardi-Castagnoli, P., Rugarli, C. and Manfredi, A. A., Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function. J. Immunol. 1998. 161: 4467-4471.
16. Schnurr, M., Scholz, C., Rothenfusser, S., Galambos, P., Dauer, M., Robe, J., Endres, S. and Eigler, A., Apoptotic pancreatic tumor cells are superior to cell lysates in promoting cross-priming of cytotoxic T cells and activate NK and gammadelta T cells. Cancer Res. 2002. 62: 2347-2352.
17. Basu, S., Binder, R. J., Suto, R., Anderson, K. M. and Srivastava, P. K., Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int. Immunol. 2000. 12: 1539-1546.
18. Berwin, B., Reed, R. C. and Nicchitta, C. V., Vitally induced lytic cell death elicits the release of immunogenic GRP94/gp96. J. Biol. Chem. 2001. 276: 21083-21088.
19. Somersan, S., Larsson, M., Fonteneau, J. F., Basu, S., Srivastava, P. and Bhardwaj, N., Primary tumor tissue lysates are enriched in heat shock proteins and induce the maturation of human dendritic cells. J. Immunol. 2001. 167: 4844-4852.
20. Binder, R. J., Han, D. K. and Srivastava, P. K., CD91: A receptor for heat shock protein gp96. Nat. Immunol. 2000. 1: 151-155.
21. Becker, T., Hartl, F. U. and Wieland, F., CD40, an extracellular receptor for binding and uptake of Hsp70-peptide complexes. J. Cell Biol. 2002. 158: 1277-1285.
22. Steinman, R. M., Turley, S., Mellman, I. and Inaba, K., The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med. 2000. 191: 411-416.
23. Sun, E. W. and Shi, Y. F., Apoptosis: the quiet death silences the immune system. Pharmacol. Ther. 2001. 92: 135-145.
24. Nestle, F. O., Banchereau, J. and Hart, D., Dendritic cells: On the move from bench to bedside. Nat. Med. 2001. 7: 761-765.
25. Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V. et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA 1993. 90: 3539-3543.
26. Rosenberg, S. A., Yang, J. C., Schwartzentruber, D. J., Hwu, P., Marincola, F. M., Topalian, S. L., Restifo, N. P. et al. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat. Med. 1998. 4: 321-327.
27. Nestle, F. O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., Burg, G. and Schadendorf, D., Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat. Med. 1998. 4: 328-332.
28. Thurner, B., Haendle, I., Roder, C., Dieckmann, D., Keikavoussi, P., Jonuleit, H., Bender, A. et al. Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J. Exp. Med. 1999. 190: 1669-1678.
29. Lee, P. P., Yee, C., Savage, P. A., Fong, L., Brockstedt, D., Weber, J. S., Johnson, D. et al. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat. Med. 1999. 5: 677-685.
30. Bennett, S. R., Carbone, F. R., Karamalis, F., Flavell, R. A., Miller, J. F. and Heath, W. R., Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 1998. 393: 478-480.
31. + T-helper and a T-killer cell. Nature 1998. 393: 474-478.
32. Schoenberger, S. P., Toes, R. E., van der Voort, E. I., Offringa, R. and Melief, C. J., T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 1998. 393: 480-483.
33. Salio, M., Cerundolo, V. and Lanzavecchia, A., Dendritic cell maturation is induced by mycoplasma infection but not by necrotic cells. Eur. J. Immunol 2000. 30: 705-708.
34. Kropshofer, H., Spindeldreher, S., Rohn, T. A., Platania, N., Grygar, C., Daniel, N., Wolpl, A. et al. Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes. Nat. Immunol. 2002. 3: 61-68.
35. Wolpl, A., Halder, T., Kalbacher, H., Neumeyer, H., Siemoneit, K., Goldmann, S. F. and Eiermann, T. H., Human monoclonal antibody with T cell-like specificity recognizes MHC class I self-peptide presented by HLA-DR1 on activated cells. Tissue Antigens 1998. 51: 258-269.
36. Bausinger, H., Lipsker, D., Ziylan, U., Manie, S., Briand, J. P., Cazenave, J. P., Muller, S. et al. Endotoxin-free heat-shock protein 70 fails to induce APC activation. Eur. J. Immunol. 2002. 32: 3708-3713.
37. Gao, B. and Tsan, M. F., Recombinant human heat shock protein 60 does not induce the release of tumor necrosis factor alpha from murine macrophages. J. Biol. Chem. 2003. 278: 22523-22529.
38. Srivastava, P. K., Menoret, A., Basu, S., Binder, R. J. and McQuade, K. L., Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world. Immunity 1998. 8: 657-665.
39. Belli, F., Testori, A., Rivoltini, L., Maio, M., Andreola, G., Sertoli, M. R., Gallino, G. et al. Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: Clinical and immunologic findings. J. Clin. Oncol. 2002. 20: 4169-4180.
40. Chicz, R. M., Urban, R. G., Gorga, J. C., Vignali, D. A., Lane, W. S. and Strominger, J. L., Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med. 1993. 178: 27-47.
41. Feng, H., Zeng, Y., Whitesell, L. and Katsanis, E., Stressed apoptotic tumor cells express heat shock proteins and elicit tumor-specific immunity. Blood 2001. 97: 3505-3512.
42. Eichmuller, S., Usener, D., Jochim, A. and Schadendorf, D., mRNA expression of tumor-associated antigens in melanoma tissues and cell lines. Exp. Dermatol. 2002. 11: 292-301.
43. Stackpole, C. W., Distinct lung-colonizing and lung-metastasizing cell populations in B16 mouse melanoma. Nature 1981. 289: 798-800.
44. Salter, R. D. and Cresswell, P., Impaired assembly and transport of HLA-A and -B antigens in a mutant T × B cell hybrid. EMBO J. 1986. 5: 943-949.
45. Li, K., Adibzadeh, M., Halder, T., Kalbacher, H., Heinzel, S., Muller, C., Zeuthen, J. and Pawelec, G., Tumour-specific MHC-class-II-restricted responses after in vitro sensitization to synthetic peptides corresponding to gp100 and annexin II eluted from melanoma cells. Cancer Immunol. Immunother. 1998. 47: 32-38.
46. Kawakami, Y., Eliyahu, S., Sakaguchi, K., Robbins, P. F., Rivoltini, L., Yannelli, J. R., Appella, E. and Rosenberg, S. A., Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J. Exp. Med. 1994. 180: 347-352.
47. Sidney, J., Oseroff, C., Southwood, S., Wall, M., Ishioka, G., Koning, F. and Sette, A., DRB1*0301 molecules recognize a structural motif distinct from the one recognized by most DR beta 1 alleles. J. Immunol. 1992. 149: 2634-2640.
48. Pieper, R., Christian, R. E., Gonzales, M. I., Nishimura, M. I., Gupta, G., Settiage, R. E., Shabanowitz, J. et al. Biochemical identification of a mutated human melanoma antigen recognized by CD4(+) T cells. J. Exp. Med. 1999. 189: 757-766.
49. Vogt, A. B., Kropshofer, H., Kalbacher, H., Kalbus, M., Rammensee, H. G., Coligan, J. E. and Martin, R., Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides. J. Immunol. 1994.153: 1665-1673.
50. + T-cell clones established from Japanese patients with insulin-dependent diabetes mellitus. Hum. Immunol. 1998. 59: 549-560.
51. Raddrizzard, L., Bono, E., Vogt, A. B., Kropshofer, H., Gallazzi, F., Sturniolo, T., Hammerling, G. J. et al. Identification of destabilizing residues in HLA class II-selected bacteriophage display libraries edited by HLA-DM. Eur. J. Immunol. 1999. 29: 660-668.
52. Arndt, S. O., Vogt, A. B., Markovic-Plese, S., Martin, R., Moldenhauer, G., Wolpl, A., Sun, Y. et al. Functional HLA-DM on the surface of B cells and immature dendritic cells. EMBO J. 2000. 19: 1241-1251.
53. Sun, Y., Sijts, A. J., Song, M., Janek, K., Nussbaum, A. K., Kral, S., Schirle, M. et al. Expression of the proteasome activator PA28 rescues the presentation of a cytotoxic T lymphocyte epitope on melanoma cells. Cancer Res. 2002. 62: 2875-2882.